GNC shares were up more than 14% early Tuesday after Bloomberg reported that Harbin Pharmaceutical Holding Group in China may make a bid to buy the Pittsburgh-based health and wellness retailer and take it private.

Earlier this year, GNC and Harbin completed a strategic partnership deal in which Harbin invested $300 million and put five members on GNC’s newly expanded board of 11 directors.

The Downtown-based vitamin retailer is scheduled to release third-quarter financial results Thursday.

GNC used the Harbin investment to help pay down part of its reported $900 million debt. It has also reached franchise agreements with Brazilian retailer BFG Brazil Comercial de Vitaminas LTDA and Rapid Nutrition in Australia, boosting its global reach.

Advertise with us

However, domestic operations have continued to struggle in the face of growing competition online and from chain stores.

GNC officials announced in November plans to close 700 to 900 stores in the U.S. and Canada over the next three years as it shifted more of its marketing efforts online as well. CEO Ken Martindale said in May that a key focus this year would be “stabilizing the U.S. business.”

The Bloomberg report, citing confidential sources, said Harbin has been in discussion with advisers about making an offer, but had not made a final decision. Speculation of a possible sale bumped GNC shares above $2.40 early in the day before pulling back and eventually closing at $2.29.

Monday’s close was $2.08.

GNC, with 5,900 retail locations in the U.S. including about 2,000 Rite Aid stores-within-a-store, has about 600 employees at its corporate headquarters Downtown.

Advertise with us

Steve Twedt: stwedt@post-gazette.com or 412-263-1963.